Related Experiment Videos
Cefotetan versus cefoxitin as prophylaxis in hysterectomy
American Journal of Obstetrics and Gynecology
|April 1, 1986
Summary
Cefotetan, a new cephalosporin, demonstrated superior bacteriologic response rates compared to cefoxitin for antimicrobial prophylaxis in hysterectomy patients. Both antibiotics showed comparable safety and clinical outcomes, with no significant side effects observed.
Area of Science:
- Infectious Diseases
- Pharmacology
- Gynecology
Background:
- Antimicrobial prophylaxis is crucial in preventing surgical site infections following hysterectomy.
- Evaluating the efficacy and safety of newer antibiotics is essential for optimizing patient care.
Purpose of the Study:
- To compare the efficacy and safety of cefotetan versus cefoxitin as antimicrobial prophylaxis for abdominal and vaginal hysterectomy.
- To assess bacteriologic response, clinical signs of infection, and postoperative outcomes.
Main Methods:
- An open, randomized, parallel study involving seventy hospitalized women undergoing hysterectomy.
- Patients received either cefotetan (a long-acting cephalosporin) or cefoxitin for antimicrobial prophylaxis.
- Outcomes measured included infection rates, bacteriologic response, temperature changes, hospitalization duration, and wound grading.
Main Results:
- Ninety-four percent of cefotetan recipients and 83% of cefoxitin recipients remained infection-free.
- Satisfactory bacteriologic response rates were significantly higher for cefotetan (91%) compared to cefoxitin (74%).
- No significant differences were observed in postoperative temperature, hospitalization duration, or wound grading between the groups.
Conclusions:
- Cefotetan exhibits a significantly better bacteriologic response rate than cefoxitin for hysterectomy prophylaxis.
- Both cefotetan and cefoxitin are safe and effective prophylactic agents with comparable clinical outcomes.
- Cefotetan represents a valuable option for antimicrobial prophylaxis in gynecologic surgery.